BR100 Decreased By (-0.88%)
BR30 Decreased By (-1.57%)
KSE100 Decreased By (-0.78%)
KSE30 Decreased By (-0.75%)
AGHA 6.70 Increased By ▲ 0.02 (0.3%)
BECO 4.37 No Change ▼ 0.00 (0%)
BML 56.00 Decreased By ▼ -1.32 (-2.3%)
BOP 30.09 Decreased By ▼ -0.26 (-0.86%)
CNERGY 12.95 Decreased By ▼ -0.17 (-1.3%)
CSIL 5.33 Decreased By ▼ -0.08 (-1.48%)
FCCL 51.50 Decreased By ▼ -1.29 (-2.44%)
FFL 14.47 Decreased By ▼ -0.25 (-1.7%)
FNEL 1.22 Increased By ▲ 0.10 (8.93%)
KEL 6.03 Decreased By ▼ -0.06 (-0.99%)
KOSM 5.84 Increased By ▲ 0.11 (1.92%)
LOTCHEM 26.20 Decreased By ▼ -0.26 (-0.98%)
MLCF 91.00 Decreased By ▼ -2.16 (-2.32%)
NBP 164.00 Decreased By ▼ -0.66 (-0.4%)
NCPL 53.00 Decreased By ▼ -2.66 (-4.78%)
NPL 59.40 Decreased By ▼ -1.76 (-2.88%)
OGDC 313.67 Decreased By ▼ -3.06 (-0.97%)
PACE 9.72 Decreased By ▼ -0.15 (-1.52%)
PAEL 35.27 Decreased By ▼ -0.36 (-1.01%)
PIBTL 14.71 Increased By ▲ 0.03 (0.2%)
PPL 221.18 Decreased By ▼ -5.73 (-2.53%)
PRL 90.91 Decreased By ▼ -2.11 (-2.27%)
PTC 58.53 Decreased By ▼ -1.73 (-2.87%)
SSGC 23.30 Decreased By ▼ -0.51 (-2.14%)
TBL 8.78 Increased By ▲ 0.03 (0.34%)
TELE 7.60 Decreased By ▼ -0.20 (-2.56%)
TPL 22.03 Decreased By ▼ -0.32 (-1.43%)
TPLP 12.60 Decreased By ▼ -0.37 (-2.85%)
TREET 21.77 Decreased By ▼ -0.39 (-1.76%)
TRG 55.91 Decreased By ▼ -0.65 (-1.15%)

ISLAMABAD: Former prime minister and founding chairman of Pakistan Tehreek-i-Insaf (PTI), Imran Khan, was brought to the Pakistan Institute of Medical Sciences (Pims) for a scheduled follow-up of his ongoing eye treatment.

Hospital officials said he received the second dose of an anti-VEGF intravitreal injection on February 24 as part of his treatment plan. Before the procedure, he was examined by a panel of specialists, including a consultant cardiologist who conducted an echocardiography and ECG, both of which were reported to be normal, along with an assessment by a consultant physician. Doctors described him as clinically stable before the intervention.

The injection was administered under standard operating protocols in the operation theatre, with monitoring and precautionary measures in place. The procedure was carried out by a consultant ophthalmologist and a vitreo-retinal surgeon from Pims, in collaboration with a specialist from Al-Shifa Eye Hospital. The treatment was performed as a day-care surgery.

Officials said he remained vitally stable before, during, and after the procedure, and was later discharged with post-procedure care instructions and follow-up advice.

In a statement issued early Tuesday, Pims hospital said Khan was examined by a board of specialists, including a consultant cardiologist who performed an echocardiography and ECG. “Mr. Imran Khan was found to be clinically stable,” the hospital said, adding that a second dose of an intravitreal Anti-VEGF injection was administered by surgeons from PIMS and Al-Shifa Eye Hospital. “The procedure was performed as day-care surgery. During the course of his stay, he remained vitally stable before, during, and after the procedure, and was discharged with instructions for care, follow-up advice, and documentation,” the statement added.

Copyright Business Recorder, 2026

Comments

Comments are closed for this article.